ArticleFrontiers in nutrition2025
Dietary intervention with Polygonatum sibiricum polysaccharides mitigates cadmium liver toxicity: a gut-liver axis perspective.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cadmium (Cd) contamination in food chains poses a global health threat, necessitating safe and effective dietary interventions. While polysaccharides are emerging as detoxifying agents, the role of Polygonatum sibiricum polysaccharides (PSP) in Cd-induced liver injury remains unexplored. This study established a female rat model of cadmium (Cd)-induced liver toxicity with PSP supplementation (125 mg/kg/day) for 8 weeks. The effect of PSP on Cd-induced hepatotoxicity was evaluated through histopathological assessment, biochemical analysis, and measurements of Cd levels in the liver and kidneys. Metabolomics and gut microbiota analysis further explored the hepatoprotective mechanisms. Results demonstrated that PSP significantly reduced serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in Cd-exposed rats, improved hepatic steatosis, and increased intestinal villi height. PSP decreased Cd accumulation in both the liver and kidney, enhanced intestinal barrier function, promoted the growth of beneficial bacteria (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.